Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Determination of sigma score based on biological variation for haemostasis assays: fit-for-purpose for daily practice?

Hollestelle MJ, Ruinemans-Koerts J, Idema RN, Meijer P, de Maat MPM.

Clin Chem Lab Med. 2019 Jan 10. pii: /j/cclm.ahead-of-print/cclm-2018-0934/cclm-2018-0934.xml. doi: 10.1515/cclm-2018-0934. [Epub ahead of print]

PMID:
30838837
2.

Comparison of thromboelastometry by ROTEM® Delta and ROTEM® Sigma in women with postpartum haemorrhage.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Bloemenkamp KWM, Eikenboom J, van der Bom JG, de Maat MPM.

Scand J Clin Lab Invest. 2019 Feb 6:1-7. doi: 10.1080/00365513.2019.1571220. [Epub ahead of print]

PMID:
30727759
3.

Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.

Donkel SJ, Benaddi B, Dippel DWJ, Ten Cate H, de Maat MPM.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):360-372. doi: 10.1161/ATVBAHA.118.312102.

4.

Monitoring of heparins in antithrombin-deficient patients.

Croles FN, Lukens MV, Mulder R, de Maat MPM, Mulder AB, Meijer K.

Thromb Res. 2019 Mar;175:8-12. doi: 10.1016/j.thromres.2019.01.007. Epub 2019 Jan 15.

PMID:
30660948
5.

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.

de Vries PS, Sabater-Lleal M, Huffman JE, Marten J, Song C, Pankratz N, Bartz TM, de Haan HG, Delgado GE, Eicher JD, Martinez-Perez A, Ward-Caviness CK, Brody JA, Chen MH, de Maat MPM, Frånberg M, Gill D, Kleber ME, Rivadeneira F, Soria JM, Tang W, Tofler GH, Uitterlinden AG, van Hylckama Vlieg A, Seshadri S, Boerwinkle E, Davies NM, Giese AK, Ikram MK, Kittner SJ, McKnight B, Psaty BM, Reiner AP, Sargurupremraj M, Taylor KD; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium, Fornage M, Hamsten A, März W, Rosendaal FR, Souto JC, Dehghan A, Johnson AD, Morrison AC, O'Donnell CJ, Smith NL.

Blood. 2019 Feb 28;133(9):967-977. doi: 10.1182/blood-2018-05-849240. Epub 2019 Jan 14.

PMID:
30642921
6.

Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversion.

Comuth WJ, de Maat MPM, van de Kerkhof D, Malczynski J, Husted S, Kristensen SD, Münster AB.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):91-99. doi: 10.1093/ehjcvp/pvy047. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):99.

PMID:
30608563
7.

Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.

Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, Delgado GE, Guo X, Bartz TM, Martinez-Perez A, Germain M, de Haan HG, Ozel AB, Polasek O, Smith AV, Eicher JD, Reiner AP, Tang W, Davies NM, Stott DJ, Rotter JI, Tofler GH, Boerwinkle E, de Maat MPM, Kleber ME, Welsh P, Brody JA, Chen MH, Vaidya D, Soria JM, Suchon P, van Hylckama Vlieg A, Desch KC, Kolcic I, Joshi PK, Launer LJ, Harris TB, Campbell H, Rudan I, Becker DM, Li JZ, Rivadeneira F, Uitterlinden AG, Hofman A, Franco OH, Cushman M, Psaty BM, Morange PE, McKnight B, Chong MR, Fernandez-Cadenas I, Rosand J, Lindgren A; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC), Gudnason V, Wilson JF, Hayward C, Ginsburg D, Fornage M, Rosendaal FR, Souto JC, Becker LC, Jenny NS, März W, Jukema JW, Dehghan A, Trégouët DA, Morrison AC, Johnson AD, O'Donnell CJ, Strachan DP, Lowenstein CJ, Smith NL.

Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532.

PMID:
30586737
8.

No independent association found between von Willebrand factor and plaque ulceration in carotid artery atherosclerosis.

Zadi T, Sonneveld M, van Dijk AC, Hussain B, Koudstaal PJ, Leebeek FWG, de Maat MPM, van der Lugt A.

Thromb Res. 2019 Feb;174:95-97. doi: 10.1016/j.thromres.2018.12.002. Epub 2018 Dec 4.

PMID:
30580083
9.

Analytical variation in factor VIII one-stage and chromogenic assays: Experiences from the ECAT external quality assessment programme.

van Moort I, Meijer P, Priem-Visser D, van Gammeren AJ, Péquériaux NCV, Leebeek FWG, Cnossen MH, de Maat MPM.

Haemophilia. 2019 Jan;25(1):162-169. doi: 10.1111/hae.13643. Epub 2018 Nov 29.

PMID:
30488994
10.

Clinically relevant differences between assays for von Willebrand factor activity.

Boender J, Eikenboom J, van der Bom JG, Meijer K, de Meris J, Fijnvandraat K, Cnossen MH, Laros-van Gorkom BAP, van Heerde WL, Mauser-Bunschoten EP, de Maat MPM, Leebeek FWG; WiN Study Group.

J Thromb Haemost. 2018 Dec;16(12):2413-2424. doi: 10.1111/jth.14319. Epub 2018 Nov 20.

PMID:
30358069
11.

Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Bloemenkamp KWM, de Maat MPM, van Roosmalen JJM, Zwart JJ, Eikenboom J, van der Bom JG; TeMpOH-1 Study Group.

Blood Adv. 2018 Oct 9;2(19):2433-2442. doi: 10.1182/bloodadvances.2018022632.

12.

High-Resolution Imaging of Interaction Between Thrombus and Stent-Retriever in Patients With Acute Ischemic Stroke.

Autar ASA, Hund HM, Ramlal SA, Hansen D, Lycklama À Nijeholt GJ, Emmer BJ, de Maat MPM, Dippel DWJ, van der Lugt A, van Es ACGM, van Beusekom HMM; MR CLEAN Registry Investigators.

J Am Heart Assoc. 2018 Jun 22;7(13). pii: e008563. doi: 10.1161/JAHA.118.008563.

13.

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Atiq F, Meijer K, Eikenboom J, Fijnvandraat K, Mauser-Bunschoten EP, van Galen KPM, Nijziel MR, Ypma PF, de Meris J, Laros-van Gorkom BAP, van der Bom JG, de Maat MP, Cnossen MH, Leebeek FWG; WiN study group.

Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.

14.

Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands.

Ruhaak LR, Romijn FPHTM, Smit NPM, van der Laarse A, Pieterse MM, de Maat MPM, Haas FJLM, Kluft C, Amiral J, Meijer P, Cobbaert CM.

Clin Chem Lab Med. 2018 Sep 25;56(10):1704-1714. doi: 10.1515/cclm-2017-1111. No abstract available.

PMID:
29708875
15.

Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study.

Wolters FJ, Boender J, de Vries PS, Sonneveld MA, Koudstaal PJ, de Maat MP, Franco OH, Ikram MK, Leebeek FW, Ikram MA.

Sci Rep. 2018 Apr 3;8(1):5474. doi: 10.1038/s41598-018-23865-7.

16.

Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration.

Comuth WJ, Henriksen LØ, van de Kerkhof D, Husted SE, Kristensen SD, de Maat MPM, Münster AB.

Thromb Res. 2018 Apr;164:32-39. doi: 10.1016/j.thromres.2018.02.141. Epub 2018 Feb 17.

PMID:
29475179
17.

Staphylococcal Protein A Is a Key Factor in Neutrophil Extracellular Traps Formation.

Hoppenbrouwers T, Sultan AR, Abraham TE, Lemmens-den Toom NA, Hansenová Maňásková S, van Cappellen WA, Houtsmuller AB, van Wamel WJB, de Maat MPM, van Neck JW.

Front Immunol. 2018 Feb 5;9:165. doi: 10.3389/fimmu.2018.00165. eCollection 2018.

18.

Neutrophil Extracellular Traps in Children With Meningococcal Sepsis.

Hoppenbrouwers T, Boeddha NP, Ekinci E, Emonts M, Hazelzet JA, Driessen GJ, de Maat MP.

Pediatr Crit Care Med. 2018 Jun;19(6):e286-e291. doi: 10.1097/PCC.0000000000001496.

PMID:
29432403
19.

Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age.

Croles FN, Van Loon JE, Dippel DWJ, De Maat MPM, Leebeek FWG.

Atherosclerosis. 2018 Feb;269:144-150. doi: 10.1016/j.atherosclerosis.2018.01.014. Epub 2018 Jan 16.

20.

The effect of bioresorbable vascular scaffold implantation on distal coronary endothelial function in dyslipidemic swine with and without diabetes.

van den Heuvel M, Sorop O, van Ditzhuijzen NS, de Vries R, van Duin RWB, Peters I, van Loon JE, de Maat MP, van Beusekom HM, van der Giessen WJ, Jan Danser AH, Duncker DJ.

Int J Cardiol. 2018 Feb 1;252:44-51. doi: 10.1016/j.ijcard.2017.11.037. Epub 2017 Nov 20.

21.

Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist.

Schellings MWM, de Maat MPM, de Lathouder S, Weerkamp F.

Clin Chem. 2017 Sep;63(9):1442-1444. doi: 10.1373/clinchem.2016.267245. No abstract available.

22.

In vitro induction of NETosis: Comprehensive live imaging comparison and systematic review.

Hoppenbrouwers T, Autar ASA, Sultan AR, Abraham TE, van Cappellen WA, Houtsmuller AB, van Wamel WJB, van Beusekom HMM, van Neck JW, de Maat MPM.

PLoS One. 2017 May 9;12(5):e0176472. doi: 10.1371/journal.pone.0176472. eCollection 2017. Review.

23.

Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study.

de Vries PS, Sabater-Lleal M, Chasman DI, Trompet S, Ahluwalia TS, Teumer A, Kleber ME, Chen MH, Wang JJ, Attia JR, Marioni RE, Steri M, Weng LC, Pool R, Grossmann V, Brody JA, Venturini C, Tanaka T, Rose LM, Oldmeadow C, Mazur J, Basu S, Frånberg M, Yang Q, Ligthart S, Hottenga JJ, Rumley A, Mulas A, de Craen AJ, Grotevendt A, Taylor KD, Delgado GE, Kifley A, Lopez LM, Berentzen TL, Mangino M, Bandinelli S, Morrison AC, Hamsten A, Tofler G, de Maat MP, Draisma HH, Lowe GD, Zoledziewska M, Sattar N, Lackner KJ, Völker U, McKnight B, Huang J, Holliday EG, McEvoy MA, Starr JM, Hysi PG, Hernandez DG, Guan W, Rivadeneira F, McArdle WL, Slagboom PE, Zeller T, Psaty BM, Uitterlinden AG, de Geus EJ, Stott DJ, Binder H, Hofman A, Franco OH, Rotter JI, Ferrucci L, Spector TD, Deary IJ, März W, Greinacher A, Wild PS, Cucca F, Boomsma DI, Watkins H, Tang W, Ridker PM, Jukema JW, Scott RJ, Mitchell P, Hansen T, O'Donnell CJ, Smith NL, Strachan DP, Dehghan A.

PLoS One. 2017 Jan 20;12(1):e0167742. doi: 10.1371/journal.pone.0167742. eCollection 2017.

24.

Fibrin improves skin wound perfusion in a diabetic rat model.

Hoppenbrouwers T, Tuk B, Fijneman EM, de Maat MP, van Neck JW.

Thromb Res. 2017 Mar;151:36-40. doi: 10.1016/j.thromres.2017.01.002. Epub 2017 Jan 10.

PMID:
28092799
25.

Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins.

Biedermann JS, van den Besselaar AM, de Maat MP, Leebeek FW, Kruip MJ.

J Thromb Haemost. 2017 Mar;15(3):500-506. doi: 10.1111/jth.13611. Epub 2017 Feb 15.

26.

Gene Variations in the Protein C and Fibrinolytic Pathway: Relevance for Severity and Outcome in Pediatric Sepsis.

Boeddha NP, Emonts M, Cnossen MH, de Maat MP, Leebeek FW, Driessen GJ, Hazelzet JA.

Semin Thromb Hemost. 2017 Feb;43(1):36-47. doi: 10.1055/s-0036-1597292. Epub 2016 Dec 15. Review.

PMID:
27978589
27.

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.

de Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, Sijbrands EJ, Franco OH, de Maat MP, Leebeek FW, Dehghan A.

Diabetologia. 2017 Feb;60(2):280-286. doi: 10.1007/s00125-016-4139-5. Epub 2016 Oct 27.

28.

von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.

Sedaghat S, de Vries PS, Boender J, Sonneveld MA, Hoorn EJ, Hofman A, de Maat MP, Franco OH, Ikram MA, Leebeek FW, Dehghan A.

Am J Kidney Dis. 2016 Nov;68(5):726-732. doi: 10.1053/j.ajkd.2016.05.032. Epub 2016 Aug 3.

PMID:
27497525
29.

Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.

Sonneveld MA, Franco OH, Ikram MA, Hofman A, Kavousi M, de Maat MP, Leebeek FW.

Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2446-2451. Epub 2016 Oct 13.

PMID:
27737864
30.

Pitfalls in the diagnosis of hemophilia severity: What to do?

van Moort I, Joosten M, de Maat MP, Leebeek FW, Cnossen MH.

Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26276. Epub 2016 Oct 13.

PMID:
27734582
31.

Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications.

de Maat MP, van Schie M, Kluft C, Leebeek FW, Meijer P.

Clin Chem. 2016 Dec;62(12):1639-1646. Epub 2016 Sep 27.

32.

Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study.

Sonneveld MA, Kavousi M, Ikram MA, Hofman A, Rueda Ochoa OL, Turecek PL, Franco OH, Leebeek FW, de Maat MP.

J Thromb Haemost. 2016 Nov;14(11):2114-2120. doi: 10.1111/jth.13479. Epub 2016 Oct 3.

33.

Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.

Libourel EJ, Klerk CPW, van Norden Y, de Maat MPM, Kruip MJ, Sonneveld P, Löwenberg B, Leebeek FWG.

Blood. 2016 Oct 6;128(14):1854-1861. doi: 10.1182/blood-2016-02-701094. Epub 2016 Jun 28.

34.

Genome-wide association studies identify genetic loci for low von Willebrand factor levels.

van Loon J, Dehghan A, Weihong T, Trompet S, McArdle WL, Asselbergs FW, Chen MH, Lopez LM, Huffman JE, Leebeek FW, Basu S, Stott DJ, Rumley A, Gansevoort RT, Davies G, Wilson JJ, Witteman JC, Cao X, de Craen AJ, Bakker SJ, Psaty BM, Starr JM, Hofman A, Jukema JW, Deary IJ, Hayward C, van der Harst P, Lowe GD, Folsom AR, Strachan DP, Smith N, de Maat MP, O'Donnell C.

Eur J Hum Genet. 2016 Jul;24(7):1096. doi: 10.1038/ejhg.2016.21. No abstract available.

35.

OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients.

Libourel EJ, Klerk C, van Norden Y, de Maat MP, Kruip MJ, Sonneveld P, Löwenberg B, Leebeek FW.

Thromb Res. 2016 Apr;140 Suppl 1:S172. doi: 10.1016/S0049-3848(16)30127-X. Epub 2016 Apr 8.

PMID:
27161682
36.

Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study.

Biedermann JS, van Rein N, van den Besselaar AM, Buhre PN, de Maat MP, van der Meer FJ, Leebeek FW, Kruip MJ.

J Thromb Haemost. 2016 Apr;14(4):695-703. doi: 10.1111/jth.13272. Epub 2016 Mar 30.

37.

A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.

de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, Tang W, Teumer A, Marioni RE, Grossmann V, Hottenga JJ, Trompet S, Müller-Nurasyid M, Zhao JH, Brody JA, Kleber ME, Guo X, Wang JJ, Auer PL, Attia JR, Yanek LR, Ahluwalia TS, Lahti J, Venturini C, Tanaka T, Bielak LF, Joshi PK, Rocanin-Arjo A, Kolcic I, Navarro P, Rose LM, Oldmeadow C, Riess H, Mazur J, Basu S, Goel A, Yang Q, Ghanbari M, Willemsen G, Rumley A, Fiorillo E, de Craen AJ, Grotevendt A, Scott R, Taylor KD, Delgado GE, Yao J, Kifley A, Kooperberg C, Qayyum R, Lopez LM, Berentzen TL, Räikkönen K, Mangino M, Bandinelli S, Peyser PA, Wild S, Trégouët DA, Wright AF, Marten J, Zemunik T, Morrison AC, Sennblad B, Tofler G, de Maat MP, de Geus EJ, Lowe GD, Zoledziewska M, Sattar N, Binder H, Völker U, Waldenberger M, Khaw KT, Mcknight B, Huang J, Jenny NS, Holliday EG, Qi L, Mcevoy MG, Becker DM, Starr JM, Sarin AP, Hysi PG, Hernandez DG, Jhun MA, Campbell H, Hamsten A, Rivadeneira F, Mcardle WL, Slagboom PE, Zeller T, Koenig W, Psaty BM, Haritunians T, Liu J, Palotie A, Uitterlinden AG, Stott DJ, Hofman A, Franco OH, Polasek O, Rudan I, Morange PE, Wilson JF, Kardia SL, Ferrucci L, Spector TD, Eriksson JG, Hansen T, Deary IJ, Becker LC, Scott RJ, Mitchell P, März W, Wareham NJ, Peters A, Greinacher A, Wild PS, Jukema JW, Boomsma DI, Hayward C, Cucca F, Tracy R, Watkins H, Reiner AP, Folsom AR, Ridker PM, O'Donnell CJ, Smith NL, Strachan DP, Dehghan A.

Hum Mol Genet. 2016 Jan 15;25(2):358-70. doi: 10.1093/hmg/ddv454. Epub 2015 Nov 10.

38.

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.

Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rottensteiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW.

Blood. 2015 Dec 17;126(25):2739-46. doi: 10.1182/blood-2015-05-643338. Epub 2015 Oct 28.

39.

Genome-wide association studies identify genetic loci for low von Willebrand factor levels.

van Loon J, Dehghan A, Weihong T, Trompet S, McArdle WL, Asselbergs FW, Chen MH, Lopez LM, Huffman JE, Leebeek FW, Basu S, Stott DJ, Rumley A, Gansevoort RT, Davies G, Wilson JJ, Witteman JC, Cao X, de Craen AJ, Bakker SJ, Psaty BM, Starr JM, Hofman A, Wouter Jukema J, Deary IJ, Hayward C, van der Harst P, Lowe GD, Folsom AR, Strachan DP, Smith N, de Maat MP, O'Donnell C.

Eur J Hum Genet. 2016 Jul;24(7):1035-40. doi: 10.1038/ejhg.2015.222. Epub 2015 Oct 21. Erratum in: Eur J Hum Genet. 2016 Jul;24(7):1096.

40.

Associations between phenotypes of preeclampsia and thrombophilia.

Berks D, Duvekot JJ, Basalan H, De Maat MP, Steegers EA, Visser W.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:199-205. doi: 10.1016/j.ejogrb.2015.09.021. Epub 2015 Sep 28.

PMID:
26444331
41.

Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR.

Biedermann JS, Leebeek FW, Buhre PN, de Lathouder S, Barends JP, de Maat MP, van der Meer FJ, Kruip MJ.

Thromb Res. 2015 Sep;136(3):652-7. doi: 10.1016/j.thromres.2015.06.037. Epub 2015 Jul 5.

PMID:
26164396
42.

Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF.

Huffman JE, de Vries PS, Morrison AC, Sabater-Lleal M, Kacprowski T, Auer PL, Brody JA, Chasman DI, Chen MH, Guo X, Lin LA, Marioni RE, Müller-Nurasyid M, Yanek LR, Pankratz N, Grove ML, de Maat MP, Cushman M, Wiggins KL, Qi L, Sennblad B, Harris SE, Polasek O, Riess H, Rivadeneira F, Rose LM, Goel A, Taylor KD, Teumer A, Uitterlinden AG, Vaidya D, Yao J, Tang W, Levy D, Waldenberger M, Becker DM, Folsom AR, Giulianini F, Greinacher A, Hofman A, Huang CC, Kooperberg C, Silveira A, Starr JM, Strauch K, Strawbridge RJ, Wright AF, McKnight B, Franco OH, Zakai N, Mathias RA, Psaty BM, Ridker PM, Tofler GH, Völker U, Watkins H, Fornage M, Hamsten A, Deary IJ, Boerwinkle E, Koenig W, Rotter JI, Hayward C, Dehghan A, Reiner AP, O'Donnell CJ, Smith NL.

Blood. 2015 Sep 10;126(11):e19-29. doi: 10.1182/blood-2015-02-624551. Epub 2015 Jun 23.

43.

Side effects of desmopressin in patients with bleeding disorders.

Stoof SC, Cnossen MH, de Maat MP, Leebeek FW, Kruip MJ.

Haemophilia. 2016 Jan;22(1):39-45. doi: 10.1111/hae.12732. Epub 2015 Jun 2.

PMID:
26036844
44.

Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity.

de Vries PS, Boender J, Sonneveld MA, Rivadeneira F, Ikram MA, Rottensteiner H, Hofman A, Uitterlinden AG, Leebeek FW, Franco OH, Dehghan A, de Maat MP.

Blood. 2015 Jun 18;125(25):3949-55. doi: 10.1182/blood-2015-02-629865. Epub 2015 May 1.

45.

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.

Sanders YV, van der Bom JG, Isaacs A, Cnossen MH, de Maat MP, Laros-van Gorkom BA, Fijnvandraat K, Meijer K, van Duijn CM, Mauser-Bunschoten EP, Eikenboom J, Leebeek FW; WiN Study Group.

J Thromb Haemost. 2015 Jun;13(6):956-66. doi: 10.1111/jth.12927. Epub 2015 May 9.

46.

von Willebrand Factor is elevated in HIV patients with a history of thrombosis.

van den Dries LW, Gruters RA, Hövels-van der Borden SB, Kruip MJ, de Maat MP, van Gorp EC, van der Ende ME.

Front Microbiol. 2015 Mar 11;6:180. doi: 10.3389/fmicb.2015.00180. eCollection 2015.

47.

Full regeneration of segmental bone defects using porous titanium implants loaded with BMP-2 containing fibrin gels.

van der Stok J, Koolen MK, de Maat MP, Yavari SA, Alblas J, Patka P, Verhaar JA, van Lieshout EM, Zadpoor AA, Weinans H, Jahr H.

Eur Cell Mater. 2015 Mar 4;29:141-53; discussion 153-4.

48.

The contribution of genetic and environmental factors to changes in total and γ' fibrinogen over 5 years.

Jobse A, Pieters M, Nienaber-Rousseau C, Boshuizen H, Hoekstra T, de Maat MP.

Thromb Res. 2015 Apr;135(4):703-9. doi: 10.1016/j.thromres.2015.01.015. Epub 2015 Jan 15.

PMID:
25613928
49.

Effects of a hemostatic powder hemospray on coagulation and clot formation.

Holster IL, van Beusekom HM, Kuipers EJ, Leebeek FW, de Maat MP, Tjwa ET.

Endoscopy. 2015 Jul;47(7):638-45. doi: 10.1055/s-0034-1391353. Epub 2015 Jan 15.

PMID:
25590183
50.

Diet and haemostasis - a comprehensive overview.

Pieters M, de Maat MP.

Blood Rev. 2015 Jul;29(4):231-41. doi: 10.1016/j.blre.2014.12.005. Epub 2014 Dec 20. Review.

PMID:
25555324

Supplemental Content

Loading ...
Support Center